Steven Brugger joined SST in 2013 as President and Chief Operating Officer. Mr. Brugger brings over 30 years of experience to SST in the biotechnology and pharmaceutical industry. He most recently served as the Chief Executive Officer at Visterra Pharmaceuticals, a private biopharmaceutical company based here in Cambridge, MA. During his 3 year tenure at Visterra, Mr. Brugger led the company in closing its initial round of financing, advancing its lead antibody program to IND, and establishing strategic partnerships with both Pfizer and the Bill and Melinda Gates Foundation. Prior to joining Visterra, Mr. Brugger was the Chief Operating Officer at Momenta Pharmaceuticals. During his 8 years at Momenta, Mr. Brugger held several leadership positions in R&D and management as the company grew from a private start-up to a successful publicly traded biopharmaceutical company. Prior to Momenta, Mr. Brugger spent over 20 years in the biotechnology and pharmaceutical industry holding various leadership and management positions at Millennium, Novartis, Ayerst, and Hoechst Pharmaceuticals. His responsibilities have included nonclinical and clinical development, strategic portfolio management, franchise program leadership, alliance management, business development, and product marketing. Steve received his BA in Biology from Susquehanna University and his MBA from the Rutgers Graduate School of Management.